Research
May 22, 2023
A randomized, placebo-controlled, double-blinded trial of the safety and efficacy of tecovirimat for the treatment of human monkeypox virus disease....
May 22, 2023
A cross-sectional study among 1500 asymptomatic gay, bisexual, and other MSM, nonbinary persons, and transgender women in NYC who have been sexually active with men since April 2022 to estimate the seroprevalence of orthopoxvirus/mpox IgG and IgM...
Apr 5, 2023
ICAP conducted an innovative cluster randomized trial aimed at rigorously evaluating the effectiveness of a combination intervention package for the provision of isoniazid preventive therapy (IPT) for tuberculosis in HIV care and treatment programs in Ethiopia, as...
Apr 4, 2023
An innovative and comprehensive approach to HIV prevention and therapeutic research. While much has been achieved in the global response to the HIV epidemic, enormous challenges remain. Only 60% of people living with HIV have access to treatment, and 1.7 million new...
Apr 4, 2023
A randomized, active-controlled, double-blind clinical study to investigate the safety and efficacy of oral Islatravir, a once-monthly pill as pre-exposure prophylaxis (PrEP) in cisgender women at high risk for HIV-1 infection. Closed to enrollment. In active study...
